Announcements Trials
Browse Landscape

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 47Observational 6

Sponsor

Cancer Type

Dermatologic 6Gynecologic 1

Conditions

Keratosis, Actinic 4Carcinoma, Basal Cell 2Keratosis 1

Interventions

Blood Specimen Collection 22Surveys and Questionnaires 19Nivolumab 14Ipilimumab 12pembrolizumab 11Gene Expression Profiling 11Biopsy 10trametinib 9dabrafenib 8Flow Cytometry 8Specimen Handling 7Polymerase Chain Reaction 7Tomography, Optical Coherence 6Therapeutics 6Immunohistochemistry 6Imiquimod 6Amplified Fragment Length Polymorphism Analysis 6Watchful Waiting 5Psychiatric Rehabilitation 5Immunotherapy 5Data Collection 53-ingenyl angelate 5Mohs Surgery 4Microarray Analysis 4Interviews as Topic 4Immunoenzyme Techniques 4Drug Therapy 4Dermoscopy 4sonidegib 3encorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × Imiquimod × Dermatologic × Clear all
NCT04809662 2024-11-07

Comparing Immune Responses to Topical Imiquimod

University of California, Davis

Terminated
6 enrolled
Dermatologic

Keratosis, Actinic

NCT06252857 2024-05-01

REDT-BCC

Maastricht University Medical Center

Unknown
142 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00189254 2022-02-07

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

Viatris Inc.

Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT01212562 2011-09-02

IMCX

University of Ioannina

Completed
70 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Graceway Pharmaceuticals, LLC

Completed
84 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡